Skip to main content

Table 4 Multivariate Cox-regression analysis of connexin expression, hormone receptors and CPS-EG classification in breast cancer patient groups

From: The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

Patient group Parameters P-value HR 95% CI
     Lower Upper
whole cohort Cx26post 0.303 0.450 0.098 2.055
  ERpost 0.050 2,739 0.999 7.504
  Cx26post 0.157 0.134 0.008 2.173
  PRpost 0.027 6.509 1.241 34.140
  CPS EG 0.967 0.000 0.000 1.381E26
EWGBSP TR2b Cx46post 0.790 4.400 0.844 22.950
  PRpost 0.115 3.809 0.722 20.111
Sataloff TB Cx46post 0.226 3.782 0.439 32.600
  PRpost 0.244 2.791 0.496 15.711
Miller-Payne G3 Cx46post 0.104 3.322 0.782 14.105
  PRpost 0.075 4.400 0.861 22.481
  1. post: after chemotherapy; HR: hazard ratio; CI: confidence intervals.